25
Participants
Start Date
July 17, 2018
Primary Completion Date
August 30, 2019
Study Completion Date
October 7, 2019
VR: 200 mg DPV + 320 mg LNG
One silicone elastomer vaginal ring (VR) containing the active ingredients dapivirine (DPV) and levonorgestrel (LNG), formulated as IPM VR: 200 mg DPV + 320 mg LNG (Ring-102)
Magee-Women'S Res Inst and Foundation, Pittsburgh
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Division of AIDS, US National Institute of Allergy and Infectious Diseases
UNKNOWN
National Institute of Mental Health (NIMH)
NIH
National Institutes of Health (NIH)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
International Partnership for Microbicides, Inc.
INDUSTRY